PA
TSVT

Parallel Advisors’s 2seventy bio TSVT Stock Holding History

Parallel Advisors’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3
Closed -$12 – 3480
2023
Q3 		$12 Sell
3
-30
-91% -$197 ﹤0.01% 3333
2023
Q2 		$334 Buy
33
+30
+1,000% +$318 ﹤0.01% 3177
2023
Q1 		$31 Hold
3
– – ﹤0.01% 3371
2022
Q4 		$28 Hold
3
– – ﹤0.01% 3305
2022
Q3 		$0 Hold
3
– – ﹤0.01% 3500
2022
Q2 		$0 Sell
3
-11
-79% -$150 ﹤0.01% 3366
2022
Q1 		$0 Buy
+14
New +$237 ﹤0.01% 3278

Other funds holding TSVT

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
ECM
Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Parallel Advisors's TSVT Position: Q4 2023 in Review

Parallel Advisors sold out of 2seventy bio (TSVT) in Q4 2023, closing a stake of 3 shares — an estimated $12 sold.

Parallel Advisors first reported a position in TSVT in Q1 2022 and held it in 7 quarters. The position peaked at $334 in Q2 2023. 116 funds tracked by Wall St. Rank hold TSVT as of Q4 2023.

  • Parallel Advisors reported no remaining 2seventy bio position as of Q4 2023 after selling out during the quarter.
  • Parallel Advisors sold 3 2seventy bio shares in Q4 2023, an estimated $12.
  • Parallel Advisors first reported a position in 2seventy bio in Q1 2022 and held it in 7 quarters.
  • Parallel Advisors's 2seventy bio position peaked at $334 in Q2 2023.
  • 116 funds tracked by Wall St. Rank held 2seventy bio as of Q4 2023.

Based on Parallel Advisors's 13F filing for Q4 2023, filed 12 Feb 2024.